Hikma Pharmaceuticals (HKMPY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hikma Pharmaceuticals

    OTC: HKMPY · Real-Time Price · USD
    49.25
    -0.15 (-0.30%)
    At close: Oct 03, 2025, 12:19 PM
    49.25
    0.00%
    Pre-market: Oct 03, 2025, 09:44 AM EDT

    Hikma Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Cash & Equivalents
    		 236M 188M 236M 205M 272M 270M 371M 426M 322M
    Short-Term Investments
    		 n/a 25M 24M 24M 22M 22M 22M 24M 24M
    Long-Term Investments
    		 11M 51M 63M 10M 29M 53M 30M 33M 26M
    Other Long-Term Assets
    		 102M 44M 268M 103M 43M 22M 39M 24M 24M
    Receivables
    		 1.07B 905M 937M 789M 905M 841M 787M 784M 695M
    Inventory
    		 1.08B 986M 936M 891M 859M 776M 765M 695M 736M
    Other Current Assets
    		 170M 86M 71M 119M 92M 80M 122M 103M 102M
    Total Current Assets
    		 2.56B 2.26B 2.29B 2.1B 2.18B 2B 2.14B 2.09B 1.96B
    Property-Plant & Equipment
    		 1.37B 1.33B 1.14B 1.14B 1.09B 1.08B 1.13B 1.15B 1.06B
    Goodwill & Intangibles
    		 1.22B 1.16B 1.09B 1.1B 1.08B 1.12B 1.25B 892M 906M
    Total Long-Term Assets
    		 3B 2.87B 2.56B 2.58B 2.44B 2.47B 2.6B 2.28B 2.23B
    Total Assets
    		 5.55B 5.13B 4.85B 4.68B 4.62B 4.47B 4.75B 4.37B 4.18B
    Account Payables
    		 611M 358M 541M 309M 505M 291M 255M 262M 226M
    Deferred Revenue
    		 n/a n/a n/a 179M 295M 193M 199M 294M 134M
    Short-Term Debt
    		 706M 642M 206M 150M 211M 139M 128M 112M 172M
    Other Current Liabilities
    		 643M 863M 486M 302M 130M 173M 143M 115M 125M
    Total Current Liabilities
    		 2.06B 1.98B 1.38B 1.34B 1.22B 1.08B 1.01B 1.02B 960M
    Long-Term Debt
    		 798M 607M 1.02B 975M 1.03B 1.07B 1.34B 651M 676M
    Other Long-Term Liabilities
    		 63M 133M 80M 77M 85M 92M 108M 140M 145M
    Total Long-Term Liabilities
    		 947M 834M 1.17B 1.13B 1.2B 1.25B 1.55B 889M 917M
    Total Liabilities
    		 3B 2.81B 2.55B 2.47B 2.42B 2.32B 2.56B 1.91B 1.88B
    Total Debt
    		 1.56B 1.31B 1.28B 1.19B 1.31B 1.28B 1.55B 846M 932M
    Book Value
    		 2.55B 2.32B 2.3B 2.21B 2.2B 2.15B 2.19B 2.47B 2.3B
    Book Value Per Share
    		 22.94 21.04 20.56 19.84 19.83 19.49 19.23 21.09 19.85
    Common Stock
    		 40M 40M 40M 40M 40M 40M 41M 42M 41M
    Retained Earnings
    		 2.47B 2.36B 2.29B 2.16B 2.15B 2.09B 2.11B 2.19B 2.03B
    Comprehensive Income
    		 n/a -337M -323M -282M -279M -279M -254M -60M -65M
    Shareholders Equity
    		 2.54B 2.31B 2.29B 2.2B 2.19B 2.13B 2.18B 2.45B 2.29B
    Total Investments
    		 11M 76M 87M 113M 51M 75M 52M 57M 36M

    Add to Watchlist